Crest Factor Analysis for Electrosurgical Ablation State Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing electrosurgical systems rely on calculated RMS values to control energy delivery, which fail to consider changes in wave shape as the device enters different operating modes, potentially leading to inaccurate tissue ablation.

Innovation Solution

Measuring the Crest Factor of the current waveform to distinguish between thermal and plasma modes, providing real-time measurements of RMS, peak current amplitudes, and Crest Factor to determine the ablative state of the electrosurgical device.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Power

If RMS values are used to control energy delivery, then power delivery control is achieved, but wave shape changes in different operating modes are not detected

Engineering Contradiction:
Improvepower delivery controlVSAvoidablative state detection accuracy
Core Design Contradiction:
PowerVSMeasurement precision

Solution Approach 1:

The patent transitions from using only RMS voltage/current values to incorporating Crest Factor (CF) as an additional parameter. The CF is calculated as the ratio of peak voltage to RMS voltage (CF = Vpeak/Vrms), providing a wave shape characteristic that changes between thermal and plasma modes. This allows the system to detect operating mode transitions while maintaining power control capability.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces Crest Factor as an intermediary parameter that bridges the gap between power control and mode detection. By calculating CF from the same voltage signal used for RMS measurement, the system gains mode detection capability without adding separate sensing hardware. The CF serves as a mediator that translates wave shape information into a usable control parameter.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Power

If RMS current measurement is used, then power control is enabled, but distinction between thermal and plasma modes is lost

Engineering Contradiction:
Improvepower controlVSAvoidwave shape information
Core Design Contradiction:
PowerVSLoss of information

Solution Approach 1:

The patent performs preliminary calculation of the Crest Factor from the measured voltage signal before using it for mode detection. By continuously calculating CF = Vpeak/Vrms from the same ADC samples used for RMS computation, the system preserves wave shape information without requiring additional measurements. This preliminary extraction of CF from existing data prevents information loss.

Inventive Principle:
Principle #10Preliminary action

3Ease of operation

If only voltage magnitude control is implemented, then simple control is maintained, but accurate ablation control in different modes is compromised

Engineering Contradiction:
Improvecontrol simplicityVSAvoidablation precision
Core Design Contradiction:
Ease of operationVSManufacturing precision

Solution Approach 1:

The patent implements dynamic control by using Crest Factor to detect transitions between thermal and plasma modes, then adjusting control parameters accordingly. The system monitors CF continuously and adapts its control strategy based on the detected mode, enabling precise ablation control across different operating conditions while maintaining a relatively simple control architecture.

Inventive Principle:
Principle #15Dynamics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Accurately determines the ablative state of the electrosurgical device, ensuring precise control of energy delivery and effective tissue ablation by differentiating between thermal and plasma modes based on wave shape analysis.

Implementation Method 1

a current sensing transformer is used to measure the amount of RF current passing through the ablation electrode

Methodology Applied
Scientific EffectElectromagnetic induction: Electromagnetic Induction

Implementation Method 2

a voltage sensing transformer may be used to derive the RMS voltage via a RMS voltage converter

Methodology Applied
Scientific EffectElectromagnetic induction: Electromagnetic Induction

Implementation Method 3

ablation is characterized by the generation of a plasma discharge at the electrode assembly of an electrosurgical probe

Methodology Applied
Scientific EffectJoule heating: Joule Heating

Implementation Method 4

when plasma discharge is initiated and the electrode assembly begins to discharge

Methodology Applied
Scientific EffectPlasma: Plasma

Data Source

PatentUS9358063B2Ablation performance indicator for electrosurgical devices
Publication Date: 2016.06.07 ARTHROCARE CORP
  • US9358063B2 patent drawing
  • US9358063B2 patent drawing
  • US9358063B2 patent drawing

AI summary

Ablation performance indicator for electrosurgical devices is described where ablation is typically characterized by the generation of a plasma discharge at the electrode assembly of an electrosurgical probe. When the electrode begins firing, the current waveform assumes a distinct appearance characterized by a spike at the leading edge of each half cycle followed by a lower level for the remaining period of the half cycle. A calculation of the waveform's Crest Factor can be used to determine the state at the electrode, e.g., whether the ablative energy is causing a desirable ablative effect on the electrode. This provides real-time measurements of the RMS and peak current amplitudes along with the Crest Factor and may also be used as limits or inputs to control algorithms or as inputs to indicate whether the device is in its ablative or non-ablative state.